Renee Black

Title: The Innovations of Inventor Renee Black

Introduction

Renee Black is a notable inventor based in Atlanta, GA (US). She has made significant contributions to the field of influenza research through her innovative work. Her dedication to advancing medical science is evident in her patented inventions.

Latest Patents

Renee Black holds a patent for the "Expression of influenza A M2 protein in baculovirus." This invention relates to baculovirus-expressed influenza antigens, specifically the influenza A membrane protein, M2, expressed from Autographa Californica nuclear polyhedrosis virus (AcNPV). The patent also describes a method to enhance the yield of baculovirus-expressed M2 proteins in host cells by culturing the recombinant baculovirus-infected host cells with an amantadine-like drug. Furthermore, her invention provides a means to utilize baculovirus-expressed M2 proteins in reproducible and routine assays for the serodiagnosis of influenza A virus infections, offering an alternative to traditional methods such as complement fixation and hemagglutination tests. She has 1 patent to her name.

Career Highlights

Renee Black's career is marked by her commitment to research and innovation in the field of virology. She has worked diligently to develop methods that improve the diagnosis and understanding of influenza A virus infections. Her work has implications for public health and disease management.

Collaborations

Renee has collaborated with esteemed colleagues, including Alan P Kendal and Paul A Rota. These partnerships have furthered her research and contributed to the advancement of knowledge in her field.

Conclusion

Renee Black's contributions to influenza research through her innovative patent demonstrate her impact on medical science. Her work continues to influence the way influenza A virus infections are diagnosed and understood.